Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 6,171 | 18,141 | 39,019 | 10,988 | 6,914 |
| Gross Profit | 6,171 | 18,141 | 39,019 | 10,988 | 6,914 |
| Operating Expenses | 82,490 | 96,244 | 104,475 | 84,510 | 64,720 |
| Operating Income | -76,319 | -78,103 | -65,456 | -73,522 | -57,806 |
| Interest Expense | 137 | 459 | 1,726 | 2,857 | 4,011 |
| Other Income | 6,536 | 5,713 | 2,170 | 132 | -1,928 |
| Pre-tax Income | -69,920 | -72,849 | -65,012 | -76,247 | -63,745 |
| Income Tax | N/A | N/A | 4,444 | N/A | N/A |
| Net Income Continuous | -69,920 | -72,849 | -69,456 | -76,247 | -63,745 |
| Net Income | $-69,920 | $-72,849 | $-69,456 | $-76,247 | $-63,745 |
| EPS Basic Total Ops | -0.38 | -0.44 | -0.46 | -0.83 | -1.00 |
| EPS Basic Continuous Ops | -0.38 | -0.44 | -0.46 | -0.72 | -0.84 |
| EPS Diluted Total Ops | -0.38 | -0.44 | -0.46 | -0.83 | -1.00 |
| EPS Diluted Continuous Ops | -0.38 | -0.44 | -0.46 | -0.72 | -0.84 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.44 | -0.46 | -0.83 | -1.00 |
| EBITDA(a) | $-74,939 | $-76,699 | $-64,029 | $-71,769 | $-55,828 |